Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ulcerative colitis

Recent news which mentions ulcerative colitis

Seres Therapeutics Ditches Its SER-301 Phase 1b Second Study In Ulcerative Colitis
Tickers MCRB
Tags Small Cap Briefs ulcerative colitis
From Benzinga
Pfizer's Ulcerative Colitis Candidate Aces Late-Stage Study
Tickers PFE
Tags Health Care Benzinga PFE
From Benzinga
Janssen's Tremfya Shows Clinical Response At 12 Weeks In Ulcerative Colitis
Tickers JNJ
Tags Health Care Benzinga News
From Benzinga
Nearly 66% Of Patients Respond To Eli Lilly's Mirikizumab In Ulcerative Colitis Study
Tickers LLY
Tags News General Benzinga
From Benzinga
Galmed's Potential Ulcerative Colitis Candidate Shows Encouraging Action In Early Study
Tickers GLMD
Tags Health Care News Trading Ideas
From Benzinga
Seres Posts Interim Microbiome Data Analysis From Failed Ulcerative Colitis Study
Tickers MCRB
Tags Small Cap Briefs ulcerative colitis
From Benzinga
Bristol Myers' Zeposia Wins European Approval For Ulcerative Colitis
Tickers BMY
Tags BMY Briefs Market News
From Benzinga
Ventyx Jumps Over 20% Today After NASDAQ Debut
Tickers BMY FPX IPO IPOS
Tags Benzinga General FPX
From Benzinga
Bristol Myers' TYK2 Inhibitor Disappoints In Mid-Stage Ulcerative Colitis Study
Tickers BMY
Tags Briefs BMY Movers
From Benzinga
Why Did Kaleido Shares Plunge 10% On Tuesday?
Tickers KLDO
Tags Trading Ideas News Health Care
From Benzinga
Galapagos' Filgotinib Shows Clinical Benefit In Ulcerative Colitis Non-Responding Patients
Tickers GLPG GLPGF
Tags Briefs GLPG Market News
From Benzinga
Eli Lilly's Mirikizumab Maintains Symptomatic Remission for Two Years In Ulcerative Colitis Patients
Tickers LLY
Tags Market News Phase 2 Trial ulcerative colitis
From Benzinga
AbbVie Submits Upadacitinib Applications In US, Europe For Ulcerative Colitis
Tickers ABBV
Tags ABBV Biotech FDA
From Benzinga
Analysts Slash Price Targets After Theravance's Failed Ulcerative Colitis Study
Tickers TBPH
Tags Price Target TBPH Biotech
From Benzinga
Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study
Tickers JNJ TBPH
Tags Phase 2 Trial Biotech TBPH
From Benzinga
Seres Therapeutics Stock Plunges As Ulcerative Colitis Candidate Disappoints In Mid-Stage Study
Tickers MCRB
Tags Biotech Phase 2 Trial MCRB
From Benzinga
Galapagos Shares Drop As SIK Inhibitor Fails To Show Positive Outcomes In Ulcerative Colitis, Rheumatoid Arthritis Patients
Tickers GLPG GLPGF
Tags Benzinga Health Care GLPGF
From Benzinga
Eli Lilly's Mirikizumab Shows Mucosal Healing In Ulcerative Colitis Maintained For Up To One Year
Tickers LLY
Tags News General Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.